BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 25449012)

  • 1. Proteomics analysis of E-cadherin knockdown in epithelial breast cancer cells.
    Vergara D; Simeone P; Latorre D; Cascione F; Leporatti S; Trerotola M; Giudetti AM; Capobianco L; Lunetti P; Rizzello A; Rinaldi R; Alberti S; Maffia M
    J Biotechnol; 2015 May; 202():3-11. PubMed ID: 25449012
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential expression of epithelial and mesenchymal proteins in a panel of prostate cancer cell lines.
    Murali AK; Norris JS
    J Urol; 2012 Aug; 188(2):632-8. PubMed ID: 22704442
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Loss of E-cadherin is not a necessity for epithelial to mesenchymal transition in human breast cancer.
    Hollestelle A; Peeters JK; Smid M; Timmermans M; Verhoog LC; Westenend PJ; Heine AA; Chan A; Sieuwerts AM; Wiemer EA; Klijn JG; van der Spek PJ; Foekens JA; Schutte M; den Bakker MA; Martens JW
    Breast Cancer Res Treat; 2013 Feb; 138(1):47-57. PubMed ID: 23338761
    [TBL] [Abstract][Full Text] [Related]  

  • 4. FOXA2 attenuates the epithelial to mesenchymal transition by regulating the transcription of E-cadherin and ZEB2 in human breast cancer.
    Zhang Z; Yang C; Gao W; Chen T; Qian T; Hu J; Tan Y
    Cancer Lett; 2015 Jun; 361(2):240-50. PubMed ID: 25779673
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The number of polyploid giant cancer cells and epithelial-mesenchymal transition-related proteins are associated with invasion and metastasis in human breast cancer.
    Fei F; Zhang D; Yang Z; Wang S; Wang X; Wu Z; Wu Q; Zhang S
    J Exp Clin Cancer Res; 2015 Dec; 34():158. PubMed ID: 26702618
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endoplasmic reticulum protein 29 regulates epithelial cell integrity during the mesenchymal-epithelial transition in breast cancer cells.
    Bambang IF; Lee YK; Richardson DR; Zhang D
    Oncogene; 2013 Mar; 32(10):1240-51. PubMed ID: 22543584
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Downregulation of β-catenin decreases the tumorigenicity, but promotes epithelial-mesenchymal transition in breast cancer cells.
    Cai K; Jiang L; Wang J; Zhang H; Wang X; Cheng D; Dou J
    J Cancer Res Ther; 2014; 10(4):1063-70. PubMed ID: 25579555
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression analysis of epithelial cadherin and related proteins in IBH-6 and IBH-4 human breast cancer cell lines.
    Lapyckyj L; Castillo LF; Matos ML; Gabrielli NM; Lüthy IA; Vazquez-Levin MH
    J Cell Physiol; 2010 Mar; 222(3):596-605. PubMed ID: 19957299
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD44 enhances the epithelial-mesenchymal transition in association with colon cancer invasion.
    Cho SH; Park YS; Kim HJ; Kim CH; Lim SW; Huh JW; Lee JH; Kim HR
    Int J Oncol; 2012 Jul; 41(1):211-8. PubMed ID: 22552741
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Cdc42/Rac1 regulator CdGAP is a novel E-cadherin transcriptional co-repressor with Zeb2 in breast cancer.
    He Y; Northey JJ; Pelletier A; Kos Z; Meunier L; Haibe-Kains B; Mes-Masson AM; Côté JF; Siegel PM; Lamarche-Vane N
    Oncogene; 2017 Jun; 36(24):3490-3503. PubMed ID: 28135249
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ZEB2 upregulates integrin α5 expression through cooperation with Sp1 to induce invasion during epithelial-mesenchymal transition of human cancer cells.
    Nam EH; Lee Y; Park YK; Lee JW; Kim S
    Carcinogenesis; 2012 Mar; 33(3):563-71. PubMed ID: 22227038
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor suppressor SCUBE2 inhibits breast-cancer cell migration and invasion through the reversal of epithelial-mesenchymal transition.
    Lin YC; Lee YC; Li LH; Cheng CJ; Yang RB
    J Cell Sci; 2014 Jan; 127(Pt 1):85-100. PubMed ID: 24213532
    [TBL] [Abstract][Full Text] [Related]  

  • 13. P-cadherin functional role is dependent on E-cadherin cellular context: a proof of concept using the breast cancer model.
    Ribeiro AS; Sousa B; Carreto L; Mendes N; Nobre AR; Ricardo S; Albergaria A; Cameselle-Teijeiro JF; Gerhard R; Söderberg O; Seruca R; Santos MA; Schmitt F; Paredes J
    J Pathol; 2013 Apr; 229(5):705-18. PubMed ID: 23180380
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Down-regulation of leucine zipper putative tumor suppressor 1 is associated with poor prognosis, increased cell motility and invasion, and epithelial-to-mesenchymal transition characteristics in human breast carcinoma.
    Wang XX; Zhu Z; Su D; Lei T; Wu X; Fan Y; Li X; Zhao J; Fu L; Dong JT; Fu L
    Hum Pathol; 2011 Oct; 42(10):1410-9. PubMed ID: 21419475
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nuclear factor I-C regulates E-cadherin via control of KLF4 in breast cancer.
    Lee HK; Lee DS; Park JC
    BMC Cancer; 2015 Mar; 15():113. PubMed ID: 25879941
    [TBL] [Abstract][Full Text] [Related]  

  • 16. EGF/EGFR axis contributes to the progression of cholangiocarcinoma through the induction of an epithelial-mesenchymal transition.
    Clapéron A; Mergey M; Nguyen Ho-Bouldoires TH; Vignjevic D; Wendum D; Chrétien Y; Merabtene F; Frazao A; Paradis V; Housset C; Guedj N; Fouassier L
    J Hepatol; 2014 Aug; 61(2):325-32. PubMed ID: 24704591
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Grhl3 induces human epithelial tumor cell migration and invasion via downregulation of E-cadherin.
    Zhao P; Guo S; Tu Z; Di L; Zha X; Zhou H; Zhang X
    Acta Biochim Biophys Sin (Shanghai); 2016 Mar; 48(3):266-74. PubMed ID: 26837418
    [TBL] [Abstract][Full Text] [Related]  

  • 18. GALNT14 mediates tumor invasion and migration in breast cancer cell MCF-7.
    Huanna T; Tao Z; Xiangfei W; Longfei A; Yuanyuan X; Jianhua W; Cuifang Z; Manjing J; Wenjing C; Shaochuan Q; Feifei X; Naikang L; Jinchao Z; Chen W
    Mol Carcinog; 2015 Oct; 54(10):1159-71. PubMed ID: 24962947
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fascin-1 expression correlates with repression of E-cadherin expression in hepatocellular carcinoma cells and augments their invasiveness in combination with matrix metalloproteinases.
    Hayashi Y; Osanai M; Lee GH
    Cancer Sci; 2011 Jun; 102(6):1228-35. PubMed ID: 21323792
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatoma-derived growth factor regulates breast cancer cell invasion by modulating epithelial--mesenchymal transition.
    Chen SC; Kung ML; Hu TH; Chen HY; Wu JC; Kuo HM; Tsai HE; Lin YW; Wen ZH; Liu JK; Yeh MH; Tai MH
    J Pathol; 2012 Oct; 228(2):158-69. PubMed ID: 22247069
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.